The US guidelines are likely to change following the release of the VANISH2 results last year, Christine Albert anticipates.

It’s no surprise that complications can vex concomitant procedures. But when staged, should PCI or TAVI come first?

Complications weren’t more common when leads were extracted. Yet there’s also the option of “jailing” leads instead.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Especially given its impact on cardiology, the WHI should be the “pride” of the US, not on the chopping block, says Martha ...

The novel dissolvable therapy had a 93.2% probability of being cost-effective at a modest willingness-to-pay level.

In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.